Conference abstract · 4 Aug 2015
Conference abstractPublished 4 Aug 2015
Future perspectives of glaucoma
Becker College, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Glaucoma is a group of eye disorders that progressively damages the optic nerve has no symptoms and no cure (yet), is a leading cause of irreversible blindness and everyone from infants to senior citizens are at risk. An estimated 60.5 million cases were found globally in 2010 and it is anticipated that number may increase to almost 80 million by 2020 and to 111.8 million by 2040. In the United States 2.2 million Americans have been diagnosed with glaucoma, of which more than 120,000 have been rendered blind. Glaucoma costs US about $2.86 billion annually. It is a matter of deep concern that many renowned physicians and glaucoma scientists including Dr David Epstein, one of the most prestigious leaders of glaucoma research are no longer with us. Based on statistical analysis it is clear that the rate of the glaucoma affected portion of the population is increasing exponentially but glaucoma research laboratories are neither increasing in number nor gaining in global popularity. The main theme of this special session is to discuss the following fundamental issues: Why has glaucoma research not yet gained popularity among scientists worldwide? What factors of glaucoma research prevent the acceleration of interdisciplinary research activities with other branches of eye research? What is the status of known factors that contribute to the pathogenesis of glaucoma?
Subjects
Ophthalmology & OptometryAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Article · 18 Dec 2025
Clinical Perspectives on Glaucoma Progression and Visual Preservation
Article · 30 Jun 2025
Glaucoma: Evolving Perspectives on Pathophysiology and Management
Conference abstract · 13 Oct 2016
Prostaglandin analogues in glaucoma - The current perspectives
Short communication · 9 Mar 2022
Biomarkers discovery for glaucoma: Future challenges and opportunities
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- SubjectOphthalmology & Optometry
- BylineArticles whose byline prints “Janardan Kumar”
